U.S. flag

An official website of the United States government

GRCh37/hg19 14q31.3-32.33(chr14:88580184-107285437)x3 AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 27, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003485051.1

Allele description [Variation Report for GRCh37/hg19 14q31.3-32.33(chr14:88580184-107285437)x3]

GRCh37/hg19 14q31.3-32.33(chr14:88580184-107285437)x3

Genes:
Variant type:
copy number gain
Cytogenetic location:
14q31.3-32.33
Genomic location:
Chr14: 88580184 - 107285437 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 14q31.3-32.33(chr14:88580184-107285437)x3
HGVS:

    Condition(s)

    Synonyms:
    none provided
    Identifiers:
    MedGen: C3661900

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...

    Assertion and evidence details

    Submission AccessionSubmitterReview Status
    (Assertion method)
    Clinical Significance
    (Last evaluated)
    OriginMethodCitations
    SCV004230800Quest Diagnostics Nichols Institute San Juan Capistrano
    criteria provided, single submitter

    (ACMG/ClinGen CNV Guidelines, 2019)
    Pathogenic
    (Jan 27, 2023)
    unknownclinical testing

    PubMed (1)
    [See all records that cite this PMID]

    Summary from all submissions

    EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
    not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

    Citations

    PubMed

    Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).

    Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, Raca G, Ritter DI, South ST, Thorland EC, Pineda-Alvarez D, Aradhya S, Martin CL.

    Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6. Erratum in: Genet Med. 2021 Nov;23(11):2230. doi: 10.1038/s41436-021-01150-9.

    PubMed [citation]
    PMID:
    31690835
    PMCID:
    PMC7313390

    Details of each submission

    From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV004230800.1

    #EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
    1not providednot providednot providednot providedclinical testing PubMed (1)

    Description

    This gain overlaps the 14q distal or terminal region and results in partial trisomy 14q. Gains falling within or overlapping the current interval have been reported in individuals with variable phenotypes (Han 2021, Sgardiolo 2013, Thiel 2008, Villa 2016). Therefore, based on gene content and current medical literature, this copy number variant (CNV) is classified as pathogenic. References: Han et al., Genes (Basel). 2021 Sep 7;12(9):1388. PMID: 34573370 Liehr et al., Front Genet. 2019 Nov 14;10:1165. PMID: 31798640 Kurtulgan et al., Mol Cytogenet. 2015 Nov 21;8:92. PMID: 26594242 Sgardioli et al., Gene. 2013 Jul 10;523(2):192-4. PMID: 23566844 Sliuzas et al., J Appl Genet. 2008;49(2):205-7. PMID: 18436995 Thiel et al., Eur J Med Genet. 2008 Jul-Aug;51(4):362-7. PMID: 18434272 Villa et al., Mol Cytogenet. 2016 Aug 5;9:60. PMID: 27499811

    #SampleMethodObservation
    OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
    1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

    Last Updated: Feb 4, 2024